In contrast to these data, Allen found concurrent decreases in both IR (measured by fasted baseline glucose/insulin ratios and QUICKI derivation) and testosterone levels in 35 obese PCOS girls randomized to either metformin or an OCP for six months [220]. The gene discussed is INS; the disease is polycystic ovary syndrome.